General Information of the Compound
| Compound ID |
CP0888133
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(3,5-dimethoxyphenyl)-N-(3-(3-((2R,6R)-2,6-dimethyltetrahydro-2H-pyran-4-yl)pyrrolidin-1-yl)propyl)-3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-amine hydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H45ClN6O3
|
||||||||||||||||||
| Molecular Weight |
621.226
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(OC)cc(N(CCCN2CCC(C3C[C@@H](C)O[C@H](C)C3)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H44N6O3.ClH/c1-23-13-26(14-24(2)43-23)25-9-12-39(22-25)10-6-11-40(29-15-30(41-4)18-31(16-29)42-5)28-7-8-32-33(17-28)37-34(20-35-32)27-19-36-38(3)21-27;/h7-8,15-21,23-26H,6,9-14,22H2,1-5H3;1H/t23-,24-,25?;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
IVHZIQUGHVXHHQ-ZTMFYPDUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01091, Fibroblast growth factor receptor 1
Protein ID: PT01411, Fibroblast growth factor receptor 3
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT00864, Vascular endothelial growth factor receptor 2